Drawing for SURROGUT

USPTO serial 79411822

SURROGUT

Reviewed by CopyMark Law Group

Reg. 8097793Status 700Registered
Filing date
Status date
Registration date
Jan 13, 2026
Examiner
O'BRIEN, JENNIFER LYNN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SURROGUT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brent E Routman

Brent E Routman Merchant & Gould, P.C.150 South 5th Street, Suite 2200, P.O. BP.O. Box 2910Minneapolis, MN 55402

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, medical and veterinary preparations, namely, pharmaceutical and medical preparations for the development, testing and evaluation of orally administered pharmaceutical products and veterinary preparations for the development, testing and evaluation of orally administered veterinary products in the nature of reagents for medical use, reagents for veterinary purposes and cell culture media for medical or veterinary purposes, namely for testing pharmaceutical, medical or veterinary products, other than for research and scientific purposes; dietetic food and substances adapted for medical or veterinary use, namely, dietetic preparations adapted for medical purposes, dietetic foods adapted for medical use, dietetic sugar substitutes for medical use, and nutritionally fortified beverages for medical use; food for babies; dietary supplements for human beings and animals; preparations for destroying vermin; fungicides, herbicidesACTIVE—
009Software, including software in the field of nutrition and pharmaceutical products, namely downloadable software for modeling, simulating and analyzing the digestion, absorption and bioavailability of orally administered pharmaceutical and food products, including prediction of blood plasma values; simulation and test equipment, namely, medical and veterinary training simulators in the nature of gastrointestinal models and laboratory testing apparatus for research laboratory use for assessing absorption, stability and bioavailability of food, pharmaceuticals, and dietary supplementsACTIVE—
010Medical apparatus and instruments including medical testing apparatus, namely, medical apparatus for testing in the nature of in-vitro gastrointestinal model apparatus for testing digestion, absorption and bioavailability of orally administered food and pharmaceutical products, medical diagnostic apparatus for testing gastrointestinal function, and apparatus for medical purposes used in medical laboratories for testing gastrointestinal motility, microbiome activity, and fluid dynamicsACTIVE—
042Scientific and technological services, namely, scientific research, analysis and testing in the field of gastrointestinal physiology, oral drug delivery, and nutrition sciences, and product research and design relating thereto; industrial analysis and research services in the field of biotechnology, pharmacology and food sciences; pharmaceutical research and analysis services in the nature of product evaluation; chemical research and analysis services; medical research; quality checking in the nature of product quality testing; testing of machinery and materials; laboratory testing services, namely, laboratory research in the field of oral drug delivery, gastrointestinal physiology, bacteriology, chemistry, toxicology, pharmaceuticals, and food sciences; rental and lease of computer software for scientific control, modelling, simulation and data analysis in the field of oral administration, drug delivery and nutrition sciences and apparatus for scientific and technological use, namely, rental of laboratory apparatus and instruments, rental of laboratory testing apparatus for pharmaceuticals and food products; toxicology research services, namely, evaluating and assessing toxicological information in relation to risks; scientific research consultancy in the field of toxicology; testing of foodstuffs; platform as a service (PAAS) featuring software platforms for transmission of images, audio-visual content, video content, data and messagesACTIVE—
044Medical services; veterinary services; hygienic and beauty care services for human beings or animals; agriculture, horticulture and forestry services, namely, food nutrition consultation relating to crops and plant-based food agricultural advice; pharmaceutical services, namely, dispensing of pharmaceuticals; pharmaceutical advice; medical analysis services relating to the treatment of persons; medical consultancy; medical testing services; nutritional advisory services; provision of information relating to nutrition; medical counseling relating to disease risk, namely, risk assessment surveys with regard to health, nutrition and medicine; medical services relating to testing of medicine; rental and lease of apparatus for medical use.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 19, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 19, 2026FIMPFINAL DISPOSITION PROCESSED—
May 28, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 11, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 11, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 13, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 13, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 13, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 25, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 25, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 19, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 29, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 28, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Oct 28, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 28, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 28, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 28, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 28, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 28, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 19, 2025RFNTREFUSAL PROCESSED BY IB—
Mar 31, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 31, 2025RFRRREFUSAL PROCESSED BY MPU—
Feb 25, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 24, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 19, 2025DOCKASSIGNED TO EXAMINER—
Dec 12, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 12, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 12, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance